You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?

Alerts

Article menu
Download PDFPDF
Young Investigators Oral Presentations (ENYGO Session)
Application of precision medicine: can molecular risk stratification provide new management options for low stage endometrioid ovarian carcinoma?
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address